Filter
1236
Text search:
drug
reaction
Featured
157
348
Language
Document type
757
198
127
74
27
22
21
5
3
2
Countries / Regions
90
37
36
34
31
30
29
28
28
24
22
21
17
16
14
14
13
12
12
11
11
10
10
10
10
8
7
7
7
7
7
6
6
5
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
502
157
44
38
28
25
23
Toolboxes
141
117
107
70
58
55
31
28
28
26
21
20
14
9
9
8
8
8
7
7
7
7
5
2
2
HIV & AIDS Treatment in Practice No.202
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial
...
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner
...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose
...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance.
...
